183 related articles for article (PubMed ID: 34379946)
21. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
Kaufman BP; Alexis AF
J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
[TBL] [Abstract][Full Text] [Related]
22. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial.
Castanedo-Cazares JP; Hernandez-Blanco D; Carlos-Ortega B; Fuentes-Ahumada C; Torres-Álvarez B
Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):35-42. PubMed ID: 24313385
[TBL] [Abstract][Full Text] [Related]
23. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
24. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
[TBL] [Abstract][Full Text] [Related]
25. Treatment of mild to moderate facial melasma with the Lumixyl topical brightening system.
Hantash BM; Jimenez F
J Drugs Dermatol; 2012 May; 11(5):660-2. PubMed ID: 22527440
[TBL] [Abstract][Full Text] [Related]
26. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
Mendoza CG; Singzon IA; Handog EB
Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
[TBL] [Abstract][Full Text] [Related]
28. Skin-lightening effects of a new face care product in patients with melasma.
Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of glycolic acid peels in the treatment of melasma.
Hurley ME; Guevara IL; Gonzales RM; Pandya AG
Arch Dermatol; 2002 Dec; 138(12):1578-82. PubMed ID: 12472345
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
Lee DB; Suh HS; Choi YS
J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.
Lima EVA; Lima MMDA; Paixão MP; Miot HA
BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309
[TBL] [Abstract][Full Text] [Related]
32. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation.
Grimes PE
Cutis; 2004 Dec; 74(6):362-8. PubMed ID: 15663072
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of 0.15% isobutylamido thiazolyl resorcinol combined with hyaluronic acid vs 0.15% isobutylamido thiazolyl resorcinol or hyaluronic acid alone in melasma treatment: A randomized evaluator-blind trial.
Disphanurat W; Srisantithum B
J Cosmet Dermatol; 2021 Nov; 20(11):3563-3572. PubMed ID: 33638926
[TBL] [Abstract][Full Text] [Related]
34. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L
J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454
[TBL] [Abstract][Full Text] [Related]
35. Topical 10% zinc sulfate solution for treatment of melasma.
Sharquie KE; Al-Mashhadani SA; Salman HA
Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534
[TBL] [Abstract][Full Text] [Related]
36. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
Rivas S; Pandya AG
Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
[TBL] [Abstract][Full Text] [Related]
37. Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study.
Kroon MW; Wind BS; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Bos JD; Wolkerstorfer A
J Am Acad Dermatol; 2011 Mar; 64(3):516-23. PubMed ID: 21255869
[TBL] [Abstract][Full Text] [Related]
38. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials.
Pennitz A; Kinberger M; Avila Valle G; Passeron T; Nast A; Werner RN
Br J Dermatol; 2022 Sep; 187(3):309-317. PubMed ID: 35290681
[TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy of liposome-encapsulated Aloe vera on melasma treatment during pregnancy.
Ghafarzadeh M; Eatemadi A
J Cosmet Laser Ther; 2017 Jun; 19(3):181-187. PubMed ID: 28139161
[TBL] [Abstract][Full Text] [Related]
40. A novel triple combination in treatment of melasma: Significant outcome with far less actives.
Pekmezci E
J Cosmet Dermatol; 2019 Dec; 18(6):1700-1704. PubMed ID: 30920111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
